首页> 外文期刊>European Journal of Drug Metabolism and Pharmacokinetics >Bioavailability and in vivo efficacy of a praziquantel–polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice
【24h】

Bioavailability and in vivo efficacy of a praziquantel–polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice

机译:吡喹酮-聚乙烯吡咯烷酮固体分散体在曼氏血吸虫感染小鼠中的生物利用度和体内功效

获取原文
获取原文并翻译 | 示例
           

摘要

One of the problems of praziquantel (PZQ) is its very low aqueous solubility. Moreover, its dissolution rate is considered the limiting factor for its bioavailability. This work correlates the physical properties and the dissolution behavior of PZQ–polyvinylpyrrolidone (PVP) solid dispersion (SD) at the ratios of 1:1 and 3:7 with its oral bioavailability and its in vivo efficacy against Schistosoma mansoni (S. mansoni). The PZQ and PZQ–PVP SD were characterized by infrared spectroscopy, differential scanning calorimetry, scanning electron microscopy (SEM) and solubility test. Results showed a decrease in crystallinity, possible interaction between PZQ and PVP, greater increase in dissolution rate and appreciable reduction in particle size. S. mansoni-infected mice treated orally with either pure PZQ or PZQ–PVP at a single dose of 500 mg/kg showed a higher increase in AUC(0–8h), C max, K a and t 1/2e with a significant decrease in k el versus the corresponding uninfected mice. Moreover, uninfected and infected mice treated with PZQ–PVP SD showed 2.3-, 1.6- and 1.3-, 1.25-fold increase, respectively, in AUC(0–8h) and C max, with a decrease in k el and increase in t 1/2e by twofold versus the corresponding pure PZQ-treated groups. Percentage worm reduction at all administered doses (62.5, 125, 250, 500 and 1,000 mg/kg) was significantly higher (1- to 1.5-fold) in mice treated with PZQ–PVP SD (ED50 = 40.92) versus those treated with pure PZQ (ED50 = 99.29). In addition, a significant reduction in total tissue egg load concomitant with a significant decrease in total immature and mature eggs and an increase in dead eggs in PZQ–PVP SD-treated groups versus their corresponding pure PZQ-treated groups was recorded. Solid dispersion of PZQ with PVP could lead to a further improvement in the effectiveness of PZQ therapy especially with the appearance of some PZQ-tolerant S. mansoni isolates.
机译:吡喹酮(PZQ)的问题之一是其极低的水溶性。此外,其溶解速率被认为是其生物利用度的限制因素。这项工作将比例为1:1和3:7的PZQ-聚乙烯吡咯烷酮(PVP)固体分散体(SD)的物理性质和溶解行为与其口服生物利用度及其对曼氏血吸虫(S. mansoni)的体内功效相关联。通过红外光谱,差示扫描量热法,扫描电子显微镜(SEM)和溶解度测试对PZQ和PZQ-PVP SD进行了表征。结果表明,结晶度降低,PZQ和PVP之间可能发生相互作用,溶出速率增加更大,而粒径明显减小。口服纯PZQ或PZQ-PVP单剂量500 mg / kg感染曼氏沙门氏菌的小鼠显示出AUC(0-8h),C max ,K a的增加更高和t 1 / 2e 与相应的未感染小鼠相比,k el 显着降低。此外,用PZQ-PVP SD处理的未感染和感染小鼠的AUC(0-8h)和C max 分别增加2.3倍,1.6倍和1.3倍,1.25倍,与相应的纯PZQ处理组相比,k el 减少,t 1 / 2e 增加两倍。与PZQ-PVP SD(ED50 = 40.92)处理的小鼠相比,所有给药剂量(62.5、125、250、500和1,000 mg / kg)的蠕虫减少率均明显更高(1-1.5倍)。用纯PZQ(ED50 = 99.29)处理的那些。此外,与相应的纯PZQ处理组相比,PZQ-PVP SD治疗组的总组织卵负荷显着减少,同时未成熟和成熟卵总量显着减少,死卵增加。 PZQ与PVP的固体分散可导致PZQ治疗效果的进一步改善,尤其是出现一些耐PZQ的曼氏葡萄球菌分离株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号